HealthBeats offers an end-to-end Remote Vitals Monitoring platform using regulatory-approved, clinical-grade devices from multiple brands to collect vitals such as temperature, blood oxygen saturation, blood pressure, blood glucose and body weight. Vitals are transmitted in real time to healthcare providers to enable proactive care management across a wide range of diseases. Led by CEO and founder Aileen Lai, the company has deployed its solution to 30 hospitals and clinics across Australia, partnering with Primary Health Networks (PHNs) and Local Health Districts (LHDs). Use cases include chronic disease management, post-hospitalisation monitoring, emergency response for Covid-19 and support for clinical trials. HealthBeats closed a US$3m Seed round and intends to use the funds to continue expanding operations and its business reach. The product focus is on integrating approved devices and servicing healthcare providers for remote patient monitoring.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

Apr 2022